Business Wire

Allied Telesis Launches SwitchBlade® x908 Generation 3 to Solve Enterprise and Data Center Scalability Challenges

17.9.2025 12:40:00 EEST | Business Wire | Press release

Share

Enterprises and data centers face mounting challenges in scaling their networks to support AI, video, IoT, and virtualized workloads. Bandwidth demand is rising, yet many organizations are held back by legacy switches, fragmented operations, and the high cost of oversized chassis systems.

To address these issues, Allied Telesis today announced the SwitchBlade x908 Generation 3 (SBx908 GEN3), a next-generation modular switch that combines high-density performance, flexible interface modularity, and future-proof scalability in a compact 3U form factor. Customers can expand capacity on demand with a wide range of interface modules, tailoring the platform to their evolving requirements.

Why SBx908 GEN3?

The SBx908 GEN3 was developed in direct response to customer demand for scalable, space-efficient networking. Its capacity-on-demand model allows customers to start with only the ports they need and expand seamlessly as traffic grows—avoiding large upfront investments. Unlike traditional systems, the SBx908 GEN3 integrates easily with both legacy copper and fiber interfaces as well as modern 25G and 400G technologies, ensuring smooth migrations without costly rip-and-replace cycles.

Solving Enterprise and Data Center Challenges

Enterprise networks struggle with:

  • Lack of scalability and redundancy in core switching
  • Manual, fragmented network operations
  • Limited predictive maintenance and asset visibility

Data centers face:

  • Backbone bandwidth bottlenecks for AI, HPC, and high-resolution video workloads
  • Legacy uplinks capped at 100G, unable to handle modern traffic patterns
  • Mixed-interface environments (10G copper, 10G fiber, 25G) that increase cost and complexity
  • High entry cost for 400G when only a few ports are required

Enterprise Core Advantages

  • Compact, powerful 3U chassis with 8 slots delivers higher density than typical 6U-class chassis systems
  • Interface modularity supports Copper 10G, Fiber 10G, and 25G for seamless legacy-to-modern integration

Data Center Advantages

  • First Allied Telesis chassis with 400G support, meeting demands of AI and HPC environments
  • Up to 64x100G ports in just 3U, addressing explosive demand for 100G connectivity
  • Optimized for server aggregation with 25G support for virtualized and containerized workloads

Differentiation

Allied Telesis takes a unified platform approach: the same hardware and AlliedWare Plus™ OS power both enterprise and data center environments. In contrast, many industry solutions separate these product lines, resulting in fragmented operations and inconsistent user experiences.

With the SBx908 GEN3, enterprises also benefit from a unified NMS (Network Management System), ensuring consistent visibility and control across all environments, simplifying operations, and reducing management overheads.

Other key differentiators include:

  • Support for 1G to 400G in a single chassis for true future-proofing
  • Capacity-on-demand flexibility to minimize upfront costs while ensuring seamless scalability
  • Compact design with unmatched density (3U, 8 slots)
  • Flexible module selection to match any deployment scenario

Proof of Performance

  • 12.8 Tbps switching fabric and 2,800 Mpps forwarding for data-intensive workloads
  • Resilient stacking and rapid failover with VCStack™ and EPSRing™ or G.8032 technologies
  • Intelligent automation via AMF Plus™, reducing operational overheads and enabling zero-touch provisioning
  • AI-powered network assistant and support for NETCONF/RESTCONF and Ansible-based automation streamline operations, reduce manual tasks, and increase productivity
  • Integrated security including Active Fiber Monitoring, AAA, and MACsec support

“Enterprises and data centers cannot afford to overspend on oversized systems or get trapped by legacy platforms,” said Rahul Gupta, Chief Technology Officer at Allied Telesis. “As another addition to the SwitchBlade x908 Series, the SwitchBlade x908 GEN3 gives customers the flexibility to scale at their own pace while delivering the high-density performance required by AI, IoT, and modern workloads.”

Availability

The SBx908 GEN3 is available worldwide through Allied Telesis authorized channel partners and resellers.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250917828690/en/

Contacts

cameron.rice@axicom.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Serbian Biotech Startup Takes Its Journey from Belgrade to Cambridge with Documentary on Longevity Science21.9.2026 14:02:00 EEST | Press release

BioEridan, a Serbian biotechnology startup backed by Telekom Srbija Group’s TS Ventures Fund, has premiered a new documentary showcasing its development of underwater Aquafarms and its ambition to contribute to the next generation of longevity science. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260921345879/en/ BioEridan Documentary Premiere BioEridan: Science Beneath the Surface premiered in Belgrade on September 15 before being screened the following day at a UK-Serbia Health, Digital Transformation & Innovation roundtable held at Christ’s College, University of Cambridge, as part of Cambridge Tech Week 2026. The roundtable brought together prominent representatives from the UK and Serbia across science, healthcare, technology, academia and business to discuss opportunities for collaboration, innovation and the commercialisation of scientific research. The documentary follows BioEridan’s development from an early scien

LabVantage Named a Visionary Leader in Life Sciences and Industrial LIMS by Frost & Sullivan21.9.2026 11:30:00 EEST | Press release

LabVantage Solutions, Inc., a leading global provider of laboratory informatics solutions and services, has been named a Visionary Leader in two 2026 Frost Radar™ reports by Frost & Sullivan: Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026 and Frost Radar™: Laboratory Information Management Systems in Industrial Applications, 2026. Announced at LabVantage’s Customer Training and Education Conference (CTEC) Europe 2026 in Paris, the dual recognition marks LabVantage’s fourth consecutive year of Frost Radar leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260921487430/en/ The Frost Radar is an independent benchmarking analysis that evaluates companies on a Growth Index and an Innovation Index. The Growth Index measures a company’s growth performance, track record, and ability to execute its growth strategy, while the Innovation Index assesses its ability to develop globally applicable solu

Bending Spoons opens office in Warsaw as Polish applications reach 50,000 in 202621.9.2026 10:15:00 EEST | Press release

Bending Spoons has opened an office in Warsaw, adding to its Milan headquarters and locations in London and Madrid. The technology company, whose portfolio includes Eventbrite and WeTransfer, has seen a sharp rise in applications from Poland and will use the new base to recruit locally for roles across key projects. “We’ve received around 50,000 applications from Poland so far this year, more than twice as many as the whole of 2025. What stands out isn’t just the volume. Many Polish candidates are among the strongest we see in our selection process, and the student talent has been particularly impressive. More than half of our recent hires from Poland were still studying when they applied,” says Andrea Maiorana, Talent data lead. Located in Śródmieście, Warsaw’s city center, the office is within walking distance of the Presidential Palace and the University of Warsaw. Bending Spoons encourages all new hires to spend their first few months in Milan, with travel and accommodation costs f

Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)21.9.2026 08:03:00 EEST | Press release

Curatis Holding AG (SIX:CURN, “Curatis”) reports net sales from goods and services of CHF 7.9m for the first half of 2026, up 51% (H1 2025: CHF 5.2m), with the loss for the period narrowing to CHF -0.4m (H1 2025: CHF -1.2m) and cash and cash equivalents rising to CHF 3.6m (31 December 2025: CHF 1.9m). Curatis also advanced its corticorelin (C-PTBE-01) program on multiple levels, including an exclusive Japan licence with Neupharma and continued manufacturing progress. Business development and finances Net sales from goods increased by 46% to CHF 7.4m (H1 2025: CHF 5.0m) and net sales from services rose to CHF 0.6m (H1 2025: CHF 0.2m). Growth was driven both by products marketed for some time and by products added to the distribution portfolio in 2025 and 2026. The gross contribution from goods and services rose by 32% to CHF 1.8m (H1 2025: CHF 1.3m); the combined cost base grew by only 9% against net sales growth of 51%, as personnel expenses rose 5% to CHF 1.3m (H1 2025: CHF 1.2m) and

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies21.9.2026 08:00:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland's leading blue chip equity benchmark comprising 20 of the country's largest and most liquid listed companies. Less than three years after its IPO on the SIX Swiss Exchange in March 2024, Galderma has established itself as one of Switzerland's leading listed companies. Its inclusion in the SMI reflects the company's strong growth, disciplined execution and increasing relevance in Swiss and international capital markets as it advances its ambition to become the world's leading dermatology powerhouse. Since its IPO, Galderma has continued to execute its growth-focused integrated dermatology strategy, delivering strong performance across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Net sales increased from 4.410 billion USD in 2024 to 5.207 billion USD in 2025, driven by science-led innovation, portfolio and geogr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye